Bioelectronica

Intelligent, digital tools to automate


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

Meet Bioelectronica: a next-gen research stage biotech company on a mission to revolutionize the way that antibody-based pharmaceutical drugs are developed. 

Specializing in intelligent, digital tools that automate and accelerate early-stage drug discovery, Bioelectronica addresses bottlenecks in pharmaceutical research to dramatically increase the rate of screening for groundbreaking drug candidates.

Have you ever wondered how new drugs are conceived, created, tested and brought to patients? Why does it take so long for a promising treatment you’ve read about in the news headlines to be available through your physician?

While there are many factors that could contribute to bottlenecks in pharmaceutical research and slow down the drug candidate discovery process, two of the biggest challenges are:

That’s where Bioelectronica’s Hypercell technology comes in.

Bioelectronica has designed a groundbreaking new system that efficiently sorts through biochemical samples to "find the needle in the haystack" by using computer vision and “anti-microfluidics” made from flexible PCB boards. The Hypercell system:

Our team is made up of industry veterans with cross-disciplinary technical expertise spanning systems engineering, cell biology, and wet chemistry. With a history of collaborating to create value for shareholders, our team is uniquely positioned to grow Bioelectronica into the leading name in the biotech space in the days ahead.

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.